aspartic acid has been researched along with gentamicin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaghan, LP; Chambers, PL | 1 |
| Bobikov, EV; Sazykin, IuO | 1 |
| Lacey, RW | 1 |
| Brownlee, RE; Hulka, GF; Pillsbury, HC; Prazma, J; Pulver, S | 1 |
| Guo, Y; Jiang, S; Yang, W | 1 |
| Guo, Y; Hu, M; Li, Z | 1 |
| Fujiwara, T; Komatsuzawa, H; McCallum, N; Nishi, H; Sugai, M | 1 |
| Frugier, M; Paulus, CA; Ryckelynck, M | 1 |
| Chen, L; Clancy, CJ; Hao, B; Kreiswirth, BN; Nguyen, MH; Perlin, DS; Shields, RK | 1 |
9 other study(ies) available for aspartic acid and gentamicin
| Article | Year |
|---|---|
The effect of gentamicin on the cockroach nerve cord.
Topics: Action Potentials; Amino Acids; Animals; Asparagine; Aspartic Acid; Cockroaches; Electrophysiology; Gentamicins; In Vitro Techniques; Male; Motor Endplate; Neurons; Synapses | 1989 |
[Effect of desoxystreptamine-containing antibiotics on incorporation of labelled amino acids and precursors of nucleic acids in different fractions of Proteus vulgaris and Pseudomonas aeruginosa].
Topics: Alanine; Amino Acids; Anti-Bacterial Agents; Aspartic Acid; Bacterial Proteins; Cell Wall; Depression, Chemical; DNA, Bacterial; Erythromycin Ethylsuccinate; Gentamicins; Glycine; Kanamycin; Leucine; Lysine; Methionine; Neomycin; Proteus; Pseudomonas aeruginosa; RNA, Bacterial; Thymine; Time Factors; Tyrosine; Uracil | 1969 |
Dwarf-colony variants of Staphylococcus aureus resistant to aminoglucoside antibiotics and to a fatty acid.
Topics: Acetates; Anti-Bacterial Agents; Aspartic Acid; Culture Media; Drug Resistance, Microbial; Framycetin; Fructose; Gentamicins; Glycosides; Humans; Kanamycin; Linoleic Acids; Microbial Sensitivity Tests; Neomycin; Oxaloacetates; Oxidation-Reduction; Paromomycin; Pyruvates; Skin; Staphylococcus; Streptomycin | 1969 |
Use of poly-l-aspartic acid to inhibit aminoglycoside cochlear ototoxicity.
Topics: Animals; Aspartic Acid; Bacillus subtilis; Cochlea; Creatinine; Evoked Potentials, Auditory, Brain Stem; Female; Gentamicins; Guinea Pigs; Hair Cells, Auditory; In Vitro Techniques; Injections, Intraperitoneal; Kidney | 1993 |
[Experimental observation of antagonism of polyaspartic acid against gentamicin-induced phospholipidosis in cochlea of guinea pig].
Topics: Animals; Aspartic Acid; Chromatography, High Pressure Liquid; Cochlea; Cochlear Diseases; Gentamicins; Guinea Pigs; Hair Cells, Auditory; Lipidoses; Male; Phospholipids | 2001 |
[Protective effect of poly DL-aspartic acid on ototoxicity of gentamicin].
Topics: Animals; Anti-Bacterial Agents; Aspartic Acid; Cell Death; Cochlea; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hair Cells, Auditory; Male; Protective Agents; Rats; Rats, Inbred F344 | 1999 |
Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Aspartic Acid; beta-Defensins; Cathelicidins; Cell Membrane; Chromatography, High Pressure Liquid; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gentamicins; Humans; Lysine; Lysophospholipids; Microbial Sensitivity Tests; Mutation; Oligosaccharides; Phosphatidylglycerols; Polysaccharides; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Vancomycin | 2004 |
Post-translational modifications guard yeast from misaspartylation.
Topics: Amino Acid Sequence; Aminoacylation; Aspartate-tRNA Ligase; Aspartic Acid; Biotin; Gene Expression; Gentamicins; Glycosylation; Lysine; Mass Spectrometry; Methylation; Models, Molecular; Molecular Sequence Data; Protein Conformation; Protein Processing, Post-Translational; Proteome; Saccharomyces cerevisiae | 2008 |
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.
Topics: Algorithms; Anti-Bacterial Agents; Aspartic Acid; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Genotype; Gentamicins; Glycine; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Porins | 2014 |